SHRINA MODI: Open Payments
NPI 1417425877 · PLAINSBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,511 in 79 payments from 15 companies in 2025. Trend: 2023 $1,675 · 2024 $2,037 · 2025 $3,511
Speaker / faculty: $2,125Food & beverage: $1,386
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 11 | $2,254 |
| ABBVIE INC. | 23 | $458 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $120 |
| Madrigal Pharmaceuticals | 6 | $108 |
| Janssen Biotech, Inc. | 4 | $95 |
| Phathom Pharmaceuticals, Inc. | 7 | $80 |
| GENZYME CORPORATION | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Lilly USA, LLC | 4 | $78 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
Products named: IBSRELA, SKYRIZI, RINVOQ, XIFAXAN, REZDIFFRA, TREMFYA, VOQUEZNA, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
